Back to Search
Start Over
Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives
- Source :
- PR Newswire. January 13, 2025
- Publication Year :
- 2025
-
Abstract
- -- Opportunity to Define a New Myelofibrosis Treatment Paradigm with Top-Line Data Readout from Phase 3 SENTRY Trial Evaluating Selinexor in Combination with Ruxolitinib in Patients with JAKi-Naȯve Myelofibrosis Anticipated [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.823298118